Photo by Joe AngelesSeigle Hall’s dedication — which takes place at 4 p.m. Sept. 25 and features a speech by Nobel Prize winner Douglass C. North, Ph.D., the Spencer T. Olin Professor in Arts & Sciences — marks a significant milestone in ongoing efforts to encourage and facilitate interdisciplinary work between the social sciences and the School of Law.
School of Medicine researchers will lead a $10 million multicenter clinical trial of an aggressive treatment for blood clots in the leg known as deep vein thrombosis.
Parents have gone home, moving boxes are put away and campus maps have been relegated to recycling bins. It’s easy to see, said freshman Bryan Lin, that the Class of 2012 has settled into life at WUSTL.
Restemayer“Politics are coming to real life on our campus. There’s excitement in the air, and it’s all students are talking about – arguing back and forth from both sides. This debate will let me see firsthand if public service is my life’s calling.” Restemayer is a young man with a mission. He’s outgoing and friendly, greeting everyone with a “Hi, I’m Bill from North Dakota,” as he’s aware there aren’t many North Dakotans on the WUSTL campus. “I like to think of myself as an ambassador for my state,” he says. He indicates he might have his sights set someday on the governor’s mansion in Bismarck, N.D. Hometown: Fargo, ND
Imran Zoberi, M.D., has been named medical director of radiation oncology at the Siteman Cancer Center at Barnes-Jewish West County Hospital. Zoberi is assistant professor of radiation oncology at the School of Medicine. As medical director, Zoberi will manage medical support staff and oversee patient care in radiation oncology at Siteman’s West County location. “When […]
The genome of a humble worm that dines on the microbial organisms covering the carcasses of dead beetles may provide clues to the evolution of parasitic worms, including those that infect humans, say scientists at the School of Medicine and the Max-Planck Institute for Developmental Biology in Germany. In a paper published in the current issue of Nature Genetics, the researchers reported finding some surprises as they have decoded the genome of the worm, a tiny nematode called Pristionchus pacificus.
A new predictive measurement, called a PEPI score, could bring good news to many women diagnosed with advanced breast cancer — a low PEPI (preoperative endocrine prognostic index) score could show that they have little risk of relapse and can safely avoid chemotherapy after surgery. For others, a high PEPI score could warn that the risk of relapse after breast surgery is large and indicate that careful follow-up and aggressive therapy may be needed, say researchers at the School of Medicine.